In a survival study, however, EphA3 deletion reduced the incidence of T-ALL in NHD13 mice, decreasing the incidence by almost half (30% NHD13-EphA3+/+ compared to 16% NHD13-EphA3−/− mice). The gene discussed is EPHA3; the disease is acute lymphoblastic leukemia.